Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endothelium, Vascular | 23 | 2021 | 4422 | 1.920 |
Why?
|
Vasodilation | 18 | 2020 | 970 | 1.710 |
Why?
|
Endothelin-1 | 8 | 2015 | 295 | 1.310 |
Why?
|
Peripheral Arterial Disease | 6 | 2024 | 1312 | 1.190 |
Why?
|
Cardiology | 5 | 2022 | 1700 | 1.060 |
Why?
|
Committee Membership | 2 | 2020 | 18 | 0.860 |
Why?
|
Vascular Diseases | 3 | 2020 | 1164 | 0.820 |
Why?
|
Societies, Medical | 3 | 2020 | 3950 | 0.800 |
Why?
|
Brachial Artery | 7 | 2020 | 376 | 0.750 |
Why?
|
Forearm | 12 | 2015 | 426 | 0.680 |
Why?
|
PPAR gamma | 3 | 2014 | 483 | 0.630 |
Why?
|
Thiazolidinediones | 3 | 2014 | 459 | 0.620 |
Why?
|
Aortic Rupture | 1 | 2021 | 322 | 0.600 |
Why?
|
Fibrinolytic Agents | 3 | 2024 | 2082 | 0.560 |
Why?
|
Arteries | 3 | 2020 | 1124 | 0.540 |
Why?
|
Hematoma | 1 | 2021 | 766 | 0.530 |
Why?
|
Endothelins | 2 | 2014 | 127 | 0.490 |
Why?
|
Venous Thromboembolism | 4 | 2023 | 1883 | 0.480 |
Why?
|
Renal Veins | 1 | 2015 | 103 | 0.480 |
Why?
|
Vasodilator Agents | 6 | 2023 | 988 | 0.470 |
Why?
|
Renal Artery | 1 | 2015 | 364 | 0.430 |
Why?
|
Biomedical Research | 2 | 2020 | 3457 | 0.420 |
Why?
|
Osteoprotegerin | 2 | 2019 | 178 | 0.410 |
Why?
|
Hypercholesterolemia | 3 | 2014 | 1148 | 0.400 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15645 | 0.400 |
Why?
|
Obesity | 11 | 2023 | 13078 | 0.390 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 318 | 0.380 |
Why?
|
Hyperinsulinism | 4 | 2012 | 402 | 0.380 |
Why?
|
Pulmonary Embolism | 5 | 2022 | 2599 | 0.380 |
Why?
|
Acetanilides | 1 | 2012 | 167 | 0.360 |
Why?
|
Anticoagulants | 6 | 2023 | 4862 | 0.330 |
Why?
|
Leadership | 1 | 2019 | 1391 | 0.320 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5187 | 0.320 |
Why?
|
Neoplasms | 6 | 2022 | 22349 | 0.320 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2822 | 0.320 |
Why?
|
Mentors | 3 | 2020 | 671 | 0.320 |
Why?
|
Peptides, Cyclic | 7 | 2015 | 390 | 0.310 |
Why?
|
Femoral Artery | 5 | 2016 | 840 | 0.310 |
Why?
|
Hospital Mortality | 3 | 2021 | 5338 | 0.300 |
Why?
|
Medical Oncology | 2 | 2022 | 2339 | 0.300 |
Why?
|
Nitroprusside | 7 | 2023 | 271 | 0.300 |
Why?
|
Flavonols | 1 | 2008 | 84 | 0.300 |
Why?
|
Cardiac Output | 1 | 2010 | 838 | 0.290 |
Why?
|
Vasoconstriction | 2 | 2015 | 594 | 0.290 |
Why?
|
Hypertension | 11 | 2016 | 8625 | 0.280 |
Why?
|
Cardiotonic Agents | 1 | 2010 | 539 | 0.280 |
Why?
|
Cacao | 1 | 2008 | 98 | 0.280 |
Why?
|
Insulin Resistance | 6 | 2014 | 3987 | 0.270 |
Why?
|
Acetylcholine | 7 | 2023 | 626 | 0.260 |
Why?
|
American Heart Association | 3 | 2022 | 1046 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2020 | 12235 | 0.250 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2018 | 127 | 0.250 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1603 | 0.220 |
Why?
|
Electrocardiography | 3 | 2018 | 6408 | 0.220 |
Why?
|
Thrombosis | 3 | 2024 | 2956 | 0.210 |
Why?
|
Stroke | 2 | 2023 | 9749 | 0.200 |
Why?
|
Infusions, Intra-Arterial | 5 | 2015 | 219 | 0.200 |
Why?
|
History, 21st Century | 2 | 2020 | 1573 | 0.200 |
Why?
|
Career Choice | 2 | 2020 | 769 | 0.200 |
Why?
|
Acute Coronary Syndrome | 2 | 2012 | 2184 | 0.200 |
Why?
|
Humans | 79 | 2024 | 765823 | 0.190 |
Why?
|
Ischemia | 3 | 2019 | 1922 | 0.190 |
Why?
|
Piperazines | 1 | 2012 | 2546 | 0.190 |
Why?
|
Nitric Oxide | 4 | 2014 | 2143 | 0.190 |
Why?
|
Hypoglycemic Agents | 5 | 2020 | 3107 | 0.180 |
Why?
|
Heart Failure | 7 | 2015 | 11838 | 0.180 |
Why?
|
History, 20th Century | 2 | 2020 | 2761 | 0.180 |
Why?
|
Gastrointestinal Hormones | 1 | 2021 | 101 | 0.170 |
Why?
|
Risk Factors | 16 | 2024 | 74853 | 0.170 |
Why?
|
Chemokine CX3CL1 | 1 | 2020 | 60 | 0.170 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 361 | 0.170 |
Why?
|
Regional Blood Flow | 7 | 2015 | 1481 | 0.170 |
Why?
|
Insulin | 5 | 2014 | 6601 | 0.170 |
Why?
|
Aortitis | 1 | 2020 | 75 | 0.170 |
Why?
|
Embolism | 1 | 2023 | 403 | 0.170 |
Why?
|
Atherosclerosis | 3 | 2023 | 3421 | 0.160 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2015 | 1396 | 0.160 |
Why?
|
Aortography | 1 | 2020 | 425 | 0.160 |
Why?
|
Acute Disease | 3 | 2022 | 7237 | 0.150 |
Why?
|
Thrombolytic Therapy | 4 | 2022 | 2059 | 0.150 |
Why?
|
District of Columbia | 2 | 2016 | 159 | 0.140 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13635 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 878 | 0.140 |
Why?
|
Popliteal Artery | 2 | 2016 | 320 | 0.140 |
Why?
|
Intermittent Claudication | 1 | 2019 | 310 | 0.130 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 345 | 0.130 |
Why?
|
Giant Cell Arteritis | 1 | 2020 | 301 | 0.130 |
Why?
|
Cross-Over Studies | 4 | 2014 | 2108 | 0.130 |
Why?
|
Carotid Stenosis | 1 | 2023 | 868 | 0.130 |
Why?
|
Cholesterol, HDL | 2 | 2018 | 1811 | 0.130 |
Why?
|
Outpatients | 1 | 2024 | 1591 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1166 | 0.130 |
Why?
|
Heparin | 1 | 2023 | 1631 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 649 | 0.130 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 873 | 0.130 |
Why?
|
Female | 41 | 2024 | 396050 | 0.120 |
Why?
|
Adipose Tissue | 4 | 2021 | 3314 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2021 | 743 | 0.120 |
Why?
|
Administration, Oral | 3 | 2020 | 4018 | 0.120 |
Why?
|
Male | 39 | 2024 | 363740 | 0.120 |
Why?
|
Nanomedicine | 1 | 2017 | 289 | 0.110 |
Why?
|
Risk Assessment | 4 | 2020 | 24278 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1001 | 0.110 |
Why?
|
Middle Aged | 32 | 2024 | 223016 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1251 | 0.110 |
Why?
|
Double-Blind Method | 7 | 2020 | 12421 | 0.110 |
Why?
|
Incretins | 1 | 2014 | 100 | 0.110 |
Why?
|
Aged | 18 | 2024 | 171178 | 0.110 |
Why?
|
Benzazepines | 2 | 2015 | 308 | 0.110 |
Why?
|
Cholesterol, LDL | 2 | 2018 | 2393 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2015 | 562 | 0.100 |
Why?
|
Peripheral Vascular Diseases | 1 | 2016 | 520 | 0.100 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2012 | 56 | 0.100 |
Why?
|
Ghrelin | 1 | 2014 | 255 | 0.100 |
Why?
|
Graft Occlusion, Vascular | 1 | 2016 | 548 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2022 | 2235 | 0.100 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2014 | 393 | 0.100 |
Why?
|
Blood Coagulation | 1 | 2018 | 1167 | 0.100 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 349 | 0.100 |
Why?
|
Guanylate Cyclase | 1 | 2013 | 205 | 0.100 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 620 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2016 | 2222 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 937 | 0.100 |
Why?
|
Cyclic GMP | 1 | 2013 | 394 | 0.100 |
Why?
|
Treatment Outcome | 14 | 2020 | 65223 | 0.090 |
Why?
|
Triglycerides | 2 | 2014 | 2441 | 0.090 |
Why?
|
Recurrence | 3 | 2021 | 8506 | 0.090 |
Why?
|
Blood Pressure | 9 | 2013 | 8532 | 0.090 |
Why?
|
Etiocholanolone | 1 | 2010 | 7 | 0.090 |
Why?
|
Fabry Disease | 2 | 2002 | 89 | 0.090 |
Why?
|
Lower Extremity | 1 | 2019 | 1226 | 0.090 |
Why?
|
Blood Vessel Prosthesis | 1 | 2016 | 959 | 0.090 |
Why?
|
Calcinosis | 1 | 2019 | 1478 | 0.090 |
Why?
|
Toll-Like Receptor 4 | 1 | 2014 | 586 | 0.090 |
Why?
|
Hospitalization | 3 | 2018 | 10803 | 0.090 |
Why?
|
rho-Associated Kinases | 1 | 2012 | 291 | 0.090 |
Why?
|
Potassium | 1 | 2015 | 1311 | 0.090 |
Why?
|
Hemorrhage | 2 | 2022 | 3464 | 0.090 |
Why?
|
Dobutamine | 1 | 2010 | 114 | 0.090 |
Why?
|
Hydrazones | 1 | 2010 | 105 | 0.090 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 132 | 0.080 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2012 | 373 | 0.080 |
Why?
|
Drug-Eluting Stents | 1 | 2016 | 683 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 674 | 0.080 |
Why?
|
Digoxin | 1 | 2010 | 246 | 0.080 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2010 | 185 | 0.080 |
Why?
|
Creatinine | 1 | 2015 | 1916 | 0.080 |
Why?
|
Th1 Cells | 1 | 2014 | 1039 | 0.080 |
Why?
|
Stents | 2 | 2023 | 3235 | 0.080 |
Why?
|
Prevalence | 3 | 2021 | 15832 | 0.080 |
Why?
|
Pyridazines | 1 | 2010 | 200 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 852 | 0.080 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2011 | 284 | 0.080 |
Why?
|
Registries | 2 | 2024 | 8320 | 0.080 |
Why?
|
Urea | 1 | 2010 | 449 | 0.070 |
Why?
|
Stroke Volume | 4 | 2016 | 5594 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2015 | 1318 | 0.070 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 968 | 0.070 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 479 | 0.070 |
Why?
|
C-Reactive Protein | 3 | 2016 | 3851 | 0.070 |
Why?
|
Hemodynamics | 2 | 2013 | 4188 | 0.070 |
Why?
|
Exercise Test | 4 | 2019 | 2184 | 0.070 |
Why?
|
Hypotension | 1 | 2013 | 883 | 0.070 |
Why?
|
Plethysmography | 2 | 2004 | 172 | 0.070 |
Why?
|
Energy Metabolism | 2 | 2021 | 2891 | 0.070 |
Why?
|
Ticlopidine | 1 | 2011 | 732 | 0.060 |
Why?
|
Interleukin-16 | 1 | 2005 | 34 | 0.060 |
Why?
|
Adipokines | 1 | 2008 | 308 | 0.060 |
Why?
|
Arteriolosclerosis | 1 | 2005 | 21 | 0.060 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2007 | 153 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1463 | 0.060 |
Why?
|
NF-kappa B | 1 | 2014 | 2487 | 0.060 |
Why?
|
Animals | 8 | 2021 | 168730 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2007 | 694 | 0.060 |
Why?
|
Education, Medical | 1 | 2017 | 1746 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2097 | 0.060 |
Why?
|
Time Factors | 5 | 2020 | 40109 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2011 | 800 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2011 | 844 | 0.060 |
Why?
|
Collateral Circulation | 1 | 2005 | 292 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2015 | 2643 | 0.060 |
Why?
|
Cause of Death | 2 | 2015 | 3710 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2007 | 1132 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3444 | 0.060 |
Why?
|
Adult | 20 | 2024 | 223055 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1727 | 0.060 |
Why?
|
Oligopeptides | 3 | 2004 | 1193 | 0.060 |
Why?
|
Heart Ventricles | 2 | 2015 | 3832 | 0.050 |
Why?
|
Glucose | 2 | 2012 | 4332 | 0.050 |
Why?
|
Dementia | 1 | 2018 | 2743 | 0.050 |
Why?
|
Cholesterol | 2 | 2003 | 2898 | 0.050 |
Why?
|
Carotid Arteries | 2 | 2023 | 937 | 0.050 |
Why?
|
Inpatients | 1 | 2015 | 2564 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 657 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3099 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3222 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6508 | 0.050 |
Why?
|
Vascular Patency | 2 | 2016 | 924 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3461 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5937 | 0.050 |
Why?
|
Myocardium | 2 | 2012 | 4763 | 0.050 |
Why?
|
Lipocalins | 1 | 2023 | 162 | 0.050 |
Why?
|
Hemorheology | 1 | 2002 | 144 | 0.050 |
Why?
|
Ascorbic Acid | 1 | 2005 | 657 | 0.050 |
Why?
|
Blood Flow Velocity | 2 | 2002 | 1382 | 0.050 |
Why?
|
Nitroglycerin | 1 | 2002 | 331 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 84 | 0.040 |
Why?
|
Piperidines | 3 | 2004 | 1662 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2015 | 2307 | 0.040 |
Why?
|
Quality of Life | 2 | 2019 | 13466 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2011 | 2136 | 0.040 |
Why?
|
Aorta | 2 | 2021 | 2037 | 0.040 |
Why?
|
Radial Artery | 1 | 2002 | 189 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3585 | 0.040 |
Why?
|
Blood Glucose | 2 | 2019 | 6422 | 0.040 |
Why?
|
Glyburide | 1 | 2020 | 117 | 0.040 |
Why?
|
Ephedrine | 1 | 1999 | 50 | 0.040 |
Why?
|
United States | 4 | 2022 | 72896 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2016 | 2112 | 0.040 |
Why?
|
Chemokine CCL5 | 1 | 2019 | 213 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2014 | 3734 | 0.040 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8039 | 0.040 |
Why?
|
Echocardiography | 3 | 2018 | 5042 | 0.040 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1999 | 175 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59506 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2020 | 22227 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 3931 | 0.040 |
Why?
|
Osteopontin | 1 | 2019 | 304 | 0.040 |
Why?
|
Prognosis | 4 | 2020 | 29915 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6544 | 0.030 |
Why?
|
Medication Errors | 1 | 2023 | 786 | 0.030 |
Why?
|
Patients | 1 | 2023 | 909 | 0.030 |
Why?
|
Pyridones | 1 | 2021 | 816 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5692 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5889 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 1999 | 653 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2020 | 81505 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3269 | 0.030 |
Why?
|
Reference Values | 3 | 2011 | 4911 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1221 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11506 | 0.030 |
Why?
|
Sugar Phosphates | 1 | 2014 | 44 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2016 | 334 | 0.030 |
Why?
|
Punctures | 1 | 2016 | 372 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1327 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1996 | 254 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2020 | 1430 | 0.030 |
Why?
|
Compartment Syndromes | 1 | 2016 | 159 | 0.030 |
Why?
|
Disaccharides | 1 | 2014 | 170 | 0.030 |
Why?
|
Hypokalemia | 1 | 2015 | 153 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2016 | 463 | 0.030 |
Why?
|
Italy | 1 | 2015 | 851 | 0.030 |
Why?
|
Prazosin | 1 | 1993 | 95 | 0.030 |
Why?
|
Rome | 1 | 2013 | 27 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1999 | 1238 | 0.030 |
Why?
|
omega-N-Methylarginine | 2 | 2004 | 108 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 4404 | 0.030 |
Why?
|
Warfarin | 1 | 2021 | 1494 | 0.030 |
Why?
|
Survival Rate | 2 | 2018 | 12821 | 0.030 |
Why?
|
Psychophysiology | 1 | 1993 | 136 | 0.030 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1993 | 170 | 0.030 |
Why?
|
Limb Salvage | 1 | 2016 | 490 | 0.030 |
Why?
|
Receptor, Endothelin A | 2 | 2002 | 55 | 0.030 |
Why?
|
Hyperkalemia | 1 | 2015 | 233 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2016 | 1603 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2014 | 277 | 0.020 |
Why?
|
Inflammation Mediators | 2 | 2014 | 1885 | 0.020 |
Why?
|
Lipids | 1 | 2003 | 3316 | 0.020 |
Why?
|
Adolescent | 4 | 2023 | 88794 | 0.020 |
Why?
|
Metformin | 1 | 2020 | 904 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 1108 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2011 | 2233 | 0.020 |
Why?
|
Inflammation | 2 | 2014 | 10845 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2005 | 4639 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2024 | 2184 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2027 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1881 | 0.020 |
Why?
|
Oxidative Stress | 2 | 2012 | 3139 | 0.020 |
Why?
|
Enalapril | 1 | 1993 | 317 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 2031 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1804 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3425 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39226 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2700 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3051 | 0.020 |
Why?
|
Angiography | 1 | 2016 | 1599 | 0.020 |
Why?
|
Aspirin | 1 | 2002 | 3135 | 0.020 |
Why?
|
Amiodarone | 1 | 2011 | 216 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23588 | 0.020 |
Why?
|
Stress, Psychological | 3 | 1996 | 4528 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 850 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 1999 | 2033 | 0.020 |
Why?
|
Ultrasonography | 1 | 2002 | 5995 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12056 | 0.020 |
Why?
|
Office Visits | 1 | 1993 | 594 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3199 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2018 | 3677 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2011 | 684 | 0.020 |
Why?
|
Systole | 1 | 2011 | 935 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2965 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2016 | 1130 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 594 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1726 | 0.020 |
Why?
|
Diastole | 1 | 2011 | 785 | 0.020 |
Why?
|
Electric Countershock | 1 | 2011 | 536 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26276 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2013 | 811 | 0.020 |
Why?
|
Life Expectancy | 1 | 2015 | 1249 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1736 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8875 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2226 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1532 | 0.020 |
Why?
|
Resistin | 1 | 2008 | 174 | 0.020 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 772 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3799 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2018 | 4497 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2011 | 737 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8725 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2213 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1590 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21501 | 0.020 |
Why?
|
Elasticity | 1 | 2007 | 652 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2011 | 841 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12966 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2011 | 1471 | 0.010 |
Why?
|
Glucose Clamp Technique | 1 | 2005 | 262 | 0.010 |
Why?
|
Phenotype | 1 | 2023 | 16706 | 0.010 |
Why?
|
Overweight | 1 | 2016 | 2443 | 0.010 |
Why?
|
Antioxidants | 1 | 2012 | 1670 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15398 | 0.010 |
Why?
|
Fatty Acids | 1 | 2012 | 1806 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13613 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9372 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8278 | 0.010 |
Why?
|
Heart Rate | 3 | 2002 | 4202 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2012 | 1670 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2745 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7872 | 0.010 |
Why?
|
Receptor, Endothelin B | 1 | 2002 | 46 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2498 | 0.010 |
Why?
|
Prospective Studies | 3 | 2011 | 54798 | 0.010 |
Why?
|
Disease Management | 1 | 2013 | 2532 | 0.010 |
Why?
|
Adiponectin | 1 | 2008 | 1120 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 2004 | 3716 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30215 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18380 | 0.010 |
Why?
|
Vasomotor System | 1 | 2002 | 208 | 0.010 |
Why?
|
E-Selectin | 1 | 2004 | 576 | 0.010 |
Why?
|
Placebos | 1 | 2005 | 1659 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2007 | 1027 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8698 | 0.010 |
Why?
|
Immune System | 1 | 2005 | 799 | 0.010 |
Why?
|
Blood Platelets | 1 | 2011 | 2464 | 0.010 |
Why?
|
Leptin | 1 | 2008 | 1597 | 0.010 |
Why?
|
Norepinephrine | 1 | 2002 | 898 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4528 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18289 | 0.010 |
Why?
|
Vascular Resistance | 1 | 2002 | 938 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7425 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6207 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18970 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2001 | 911 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10570 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10087 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9355 | 0.010 |
Why?
|
Child | 2 | 2018 | 80509 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4350 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1999 | 1587 | 0.010 |
Why?
|
Brain | 1 | 2021 | 27178 | 0.010 |
Why?
|
Mice | 2 | 2012 | 81788 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59849 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10723 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14445 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 1993 | 899 | 0.010 |
Why?
|
Rest | 1 | 1993 | 940 | 0.000 |
Why?
|
Cohort Studies | 1 | 2011 | 41643 | 0.000 |
Why?
|
Body Mass Index | 1 | 2003 | 13041 | 0.000 |
Why?
|
Algorithms | 1 | 2002 | 14062 | 0.000 |
Why?
|